Patent ID: 8496976
Filing Date: 2013-07-30
Classification: A61K,A61P

Abstract:
1. A composition for the treatment of dry eye syndrome in a human or mammal in need thereof, the composition consisting essentially of therapeutically effective amounts of: linseed oil; castor oil; one or more tonicity agents selected from the group consisting of glycerin, erythritol, mannitol, sorbitol, xylitol, dextrose, carnitine, propylene glycol, sodium chloride, and potassium chloride; one or more surfactants selected from the group consisting of polysorbate, polyoxyl stearate, glyceryl stearate, and isopropyl stearate; one or more viscosity enhancers selected from the group consisting of carboxymethyl cellulose, hyaluronic acid, and crosslinked copolymers of acrylic acid and C10-C30 alkyl acrylate; stabilized oxychloro complex; and, at least one buffering and pH adjusting agent selected from the group consisting of hydrochloric acid, sodium hydroxide, boric acid, citrate salts, phosphate salts, lactate salts, and ammonium salts.